The American Journal of Managed Care16 小时
Enhancing Retinal Disease Outcomes With Anti-VEGF Therapies
New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients ...
PipelineReview.com23 小时
Avirmax Biopharma Initiates IND-enabling Studies of ABI-201; a Breakthrough Gene Therapy ...
HAYWARD, CA, USA I February 28, 2025 I Avirmax Biopharma, Inc., a leader in developing the next generation of AAV gene therapies, today announced the ...